405 related articles for article (PubMed ID: 30566847)
1. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.
Newton CA; Zhang D; Oldham JM; Kozlitina J; Ma SF; Martinez FJ; Raghu G; Noth I; Garcia CK
Am J Respir Crit Care Med; 2019 Aug; 200(3):336-347. PubMed ID: 30566847
[No Abstract] [Full Text] [Related]
2. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
Zhang D; Adegunsoye A; Oldham JM; Kozlitina J; Garcia N; Poonawalla M; Strykowski R; Linderholm AL; Ley B; Ma SF; Noth I; Strek ME; Wolters PJ; Garcia CK; Newton CA
Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37591536
[TBL] [Abstract][Full Text] [Related]
3. TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Oldham JM; Ma SF; Martinez FJ; Anstrom KJ; Raghu G; Schwartz DA; Valenzi E; Witt L; Lee C; Vij R; Huang Y; Strek ME; Noth I;
Am J Respir Crit Care Med; 2015 Dec; 192(12):1475-82. PubMed ID: 26331942
[TBL] [Abstract][Full Text] [Related]
4. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.
Stuart BD; Lee JS; Kozlitina J; Noth I; Devine MS; Glazer CS; Torres F; Kaza V; Girod CE; Jones KD; Elicker BM; Ma SF; Vij R; Collard HR; Wolters PJ; Garcia CK
Lancet Respir Med; 2014 Jul; 2(7):557-65. PubMed ID: 24948432
[TBL] [Abstract][Full Text] [Related]
5. Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial.
Podolanczuk AJ; Kim JS; Cooper CB; Lasky JA; Murray S; Oldham JM; Raghu G; Flaherty KR; Spino C; Noth I; Martinez FJ;
BMC Pulm Med; 2022 Dec; 22(1):475. PubMed ID: 36514019
[TBL] [Abstract][Full Text] [Related]
6. Telomere length and genetic variant associations with interstitial lung disease progression and survival.
Newton CA; Oldham JM; Ley B; Anand V; Adegunsoye A; Liu G; Batra K; Torrealba J; Kozlitina J; Glazer C; Strek ME; Wolters PJ; Noth I; Garcia CK
Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635297
[TBL] [Abstract][Full Text] [Related]
7. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
[TBL] [Abstract][Full Text] [Related]
8. Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.
Newton CA; Kozlitina J; Lines JR; Kaza V; Torres F; Garcia CK
J Heart Lung Transplant; 2017 Aug; 36(8):845-853. PubMed ID: 28262440
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.
Nambiar AM; Anzueto AR; Peters JI
PLoS One; 2017; 12(4):e0176312. PubMed ID: 28441449
[TBL] [Abstract][Full Text] [Related]
10. Association between telomere length and survival in patients with idiopathic pulmonary fibrosis.
Dai J; Cai H; Li H; Zhuang Y; Min H; Wen Y; Yang J; Gao Q; Shi Y; Yi L
Respirology; 2015 Aug; 20(6):947-52. PubMed ID: 26073170
[TBL] [Abstract][Full Text] [Related]
11. Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.
Popescu I; Mannem H; Winters SA; Hoji A; Silveira F; McNally E; Pipeling MR; Lendermon EA; Morrell MR; Pilewski JM; Hanumanthu VS; Zhang Y; Gulati S; Shah PD; Iasella CJ; Ensor CR; Armanios M; McDyer JF
Am J Respir Crit Care Med; 2019 Feb; 199(3):362-376. PubMed ID: 30088779
[TBL] [Abstract][Full Text] [Related]
12. Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis.
Paterniti MO; Bi Y; Rekić D; Wang Y; Karimi-Shah BA; Chowdhury BA
Ann Am Thorac Soc; 2017 Sep; 14(9):1395-1402. PubMed ID: 28388260
[TBL] [Abstract][Full Text] [Related]
13. Relation between sex hormones and leucocyte telomere length in men with idiopathic pulmonary fibrosis.
Fang C; Huang H; Zhang Q; Wang N; Jing X; Guo J; Ferianc M; Xu Z
Respirology; 2020 Dec; 25(12):1265-1273. PubMed ID: 32583532
[TBL] [Abstract][Full Text] [Related]
14. From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.
van Batenburg AA; Kazemier KM; van Oosterhout MFM; van der Vis JJ; van Es HW; Grutters JC; Goldschmeding R; van Moorsel CHM
PLoS One; 2020; 15(1):e0226785. PubMed ID: 31910222
[TBL] [Abstract][Full Text] [Related]
15. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Behr J; Bendstrup E; Crestani B; Günther A; Olschewski H; Sköld CM; Wells A; Wuyts W; Koschel D; Kreuter M; Wallaert B; Lin CY; Beck J; Albera C
Lancet Respir Med; 2016 Jun; 4(6):445-53. PubMed ID: 27161257
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis.
Lee JS; La J; Aziz S; Dobrinskikh E; Brownell R; Jones KD; Achtar-Zadeh N; Green G; Elicker BM; Golden JA; Matthay MA; Kukreja J; Schwartz DA; Wolters PJ
Histopathology; 2021 Jul; 79(1):67-76. PubMed ID: 33432658
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial.
Raghu G; Depaso WJ; Cain K; Hammar SP; Wetzel CE; Dreis DF; Hutchinson J; Pardee NE; Winterbauer RH
Am Rev Respir Dis; 1991 Aug; 144(2):291-6. PubMed ID: 1859050
[TBL] [Abstract][Full Text] [Related]
19. Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications.
Hannan SJ; Iasella CJ; Sutton RM; Popescu ID; Koshy R; Burke R; Chen X; Zhang Y; Pilewski JM; Hage CA; Sanchez PG; Im A; Farah R; Alder JK; McDyer JF
Am J Transplant; 2023 Oct; 23(10):1590-1602. PubMed ID: 37392813
[TBL] [Abstract][Full Text] [Related]
20. Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Walter N; Collard HR; King TE
Proc Am Thorac Soc; 2006 Jun; 3(4):330-8. PubMed ID: 16738197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
